- Dr. Reddy’s Laboratories Ltd. has received the Establishment Inspection Report (EIR) from the USFDA for its formulations manufacturing facilities (FTO-7 & FTO-9) in Duvvada, Visakhapatnam.
Unlock the Full Filing And Lot More
Access premium insights and stay ahead of the market with Dzambhala Pro.
Learn More
DRREDDY PRIOR FILINGS
- 2d ago
- 2d ago
- 13d ago
- 21d ago
- 1mo ago
Dr. Reddy's Laboratories Set to Release Q3FY25 Financial Results on January 23, Earnings Call Sched…
Dr. Reddy's Sells Non-Strategic Subsidiary in USA for USD 1, Contributing ₹320 Cr in Turnover
Dr. Reddy's Laboratories' Bank Facilities Rated ₹2,000 Cr by ICRA with Stable Outlook
Dr. Reddy's Allots 13,080 Equity Shares Under Employees Stock Option Scheme
Dr. Reddy's Ukraine Subsidiary Slapped with EUR 280 Penalty by State Tax Service
ALL LATEST FILINGS
- 40m ago
- 40m ago
- 1h ago
- 1h ago
- 2h ago
Bajaj Auto Schedules Conference Call on January 28 to Discuss Q3 FY25 Results
Escorts Kubota Set to Launch Promaxx Series in Agri Machinery Segment
UltraTech Cement Reports Significant Share Price Movement Without Any Related News
Grasim Industries Completes ₹500 Cr Full Repayment of Commercial Paper on Maturity
Suzlon Energy Allots 2.5 Lac Shares Under ESOP 2022, Raising ₹12.5 Lac